Abstract
Hepcidin-25 is thought to be the central regulator of body iron metabolism. Since the clinical characteristics of the anemias of chronic inflammation are similar to anemia found in cancer, and since several tumor types are associated with increased cytokine production, especially hepcidin has been addressed as an explanation for the associated anemia in these conditions. 14 patients with non-Hodgkin lymphoman, 12 patients with Hodgkin lymphoma and 24 patients with multiple myeloma enrolled in this study. Serum hepciden was measured in all patients using ELISA. Conclusion. Hepcidin levels are significantly higher in anemic patients with MM, HL and NHL. Hepcidin levels are inversely correlated with Hb levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Innovative Research and Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
